Marie Cullberg

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Top Venues

Clinical pharmacokinetics

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics (2024)
Carlos Fernández-Teruel, Marie Cullberg, Cath Eberlein, Simon T Barry, Diansong Zhou
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours. Clinical pharmacokinetics 63 (8) (2024)
Veronika Voronova, Marie Cullberg, Philip Delff, Joanna Parkinson, Corina Dota, Gaia Schiavon, Brijesh Maroj, Dinko Rekić, S Y Amy Cheung
Concentration-QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations. British journal of clinical pharmacology (2021)